- Home
- CCM vs FGEN Comparison
CCM vs FGEN Comparison
Compare CCM & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- FGEN
- Stock Information
- Founded
- CCM 1997
- FGEN 1993
- Country
- CCM China
- FGEN United States
- Employees
- CCM N/A
- FGEN N/A
- Industry
- CCM Medical/Nursing Services
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- FGEN Health Care
- Exchange
- CCM Nasdaq
- FGEN Nasdaq
- Market Cap
- CCM 33.3M
- FGEN 33.5M
- IPO Year
- CCM 2009
- FGEN 2014
- Fundamental
- Price
- CCM $5.50
- FGEN $7.69
- Analyst Decision
- CCM
- FGEN Strong Buy
- Analyst Count
- CCM 0
- FGEN 1
- Target Price
- CCM N/A
- FGEN $250.00
- AVG Volume (30 Days)
- CCM 1.8K
- FGEN 74.7K
- Earning Date
- CCM 04-25-2025
- FGEN 08-05-2025
- Dividend Yield
- CCM N/A
- FGEN N/A
- EPS Growth
- CCM N/A
- FGEN N/A
- EPS
- CCM N/A
- FGEN N/A
- Revenue
- CCM $52,603,198.00
- FGEN $6,996,000.00
- Revenue This Year
- CCM N/A
- FGEN N/A
- Revenue Next Year
- CCM N/A
- FGEN N/A
- P/E Ratio
- CCM N/A
- FGEN N/A
- Revenue Growth
- CCM N/A
- FGEN N/A
- 52 Week Low
- CCM $3.80
- FGEN $4.50
- 52 Week High
- CCM $10.50
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- CCM 33.47
- FGEN 64.36
- Support Level
- CCM $5.20
- FGEN $7.03
- Resistance Level
- CCM $5.68
- FGEN $5.73
- Average True Range (ATR)
- CCM 0.14
- FGEN 0.50
- MACD
- CCM -0.01
- FGEN 0.35
- Stochastic Oscillator
- CCM 29.66
- FGEN 100.00
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.